Agios Pharmaceuticals | Kostnadene For Salg

Cost Of Sales Endring Dato
AbbVie USD 4.09B 181M 2024-03
Agios Pharmaceuticals USD 627K 41K 2024-03
Alnylam Pharmaceuticals USD 65.98M 19.88M 2024-03
Amgen USD 3.2B 88M 2024-03
Astellas Pharma JPY 75.9B 1.49B 2023-12
AstraZeneca USD 2.22B 63M 2024-03
Bayer EUR 5.46B 977M 2024-03
Biogen USD 542.2M 76.1M 2024-03
BioMarin Pharmaceutical USD 125.18M 10.3M 2024-03
Bristol-Myers Squibb USD 2.93B 225M 2024-03
Daiichi Sankyo JPY 122.35B 27.61B 2023-12
Eli Lilly USD 1.67B 114.5M 2024-03
Exelixis USD 21.26M 2.48M 2024-03
Gilead Sciences USD 1.55B 59M 2024-03
GlaxoSmithKline GBP 1.97B 363M 2024-03
Incyte USD 61M 3.05M 2024-03
Ionis Pharmaceuticals USD 2.15M 911K 2024-03
Merck USD 3.54B 200M 2024-03
Moderna USD 96M 833M 2024-03
Novartis USD 3.1B 109M 2024-03
Novartis USD 3.1B 109M 2024-03
Pfizer USD 3.38B 3.29B 2024-03
Regeneron Pharmaceuticals USD 433.8M 83.2M 2024-03
Roche Holding CHF 7.62B 1.33B 2023-06
Sarepta Therapeutics USD 50.56M 13.53M 2024-03
Vertex Pharmaceuticals USD 342.6M 23.9M 2024-03



Agios Pharmaceuticals Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.